[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @provue_ai Provue Provue posts on X about johnson johnson, $2399b, investments, $937b the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1913227952671666176/interactions)  - X Week XXXXX +43% - X Month XXXXX +18% ### Mentions: X [#](/creator/twitter::1913227952671666176/posts_active)  - X Week X +29% - X Month XX -XX% ### Followers: XXX [#](/creator/twitter::1913227952671666176/followers)  - X Week XXX +4% - X Month XXX +93% ### CreatorRank: undefined [#](/creator/twitter::1913227952671666176/influencer_rank)  ### Social Influence [#](/creator/twitter::1913227952671666176/influence) --- **Social category influence** [stocks](/list/stocks) XX% **Social topic influence** [johnson johnson](/topic/johnson-johnson) 10%, [$2399b](/topic/$2399b) 10%, [investments](/topic/investments) 10%, [$937b](/topic/$937b) XX% **Top accounts mentioned or mentioned by** [@thedulab](/creator/undefined) [@tcs](/creator/undefined) [@provueai](/creator/undefined) [@chanderbhatia01](/creator/undefined) [@cjjohnson17th](/creator/undefined) [@itsnitinverma](/creator/undefined) [@wealthenrich](/creator/undefined) **Top assets mentioned** [Johnson & Johnson (JNJ)](/topic/johnson-johnson) ### Top Social Posts [#](/creator/twitter::1913227952671666176/posts) --- Top posts by engagements in the last XX hours "Johnson & Johnson Q3 2025 delivered steady growth alongside active portfolio moves. - Sales came in at $23.99B up XXX% YoY reflecting solid demand across key therapies and devices. - Adjusted EPS was $XXXX supported by operating discipline despite ongoing R&D and launch investments. - For 2025 management reaffirmed guidance with a sales midpoint of $93.7B and EPS outlook maintained signaling confidence in the trajectory. - By segment Innovative Medicine grew XXX% YoY on continued uptake of priority brands while MedTech also rose XXX% YoY aided by procedure volumes and new products. - On the" [X Link](https://x.com/provue_ai/status/1978760600902885879) [@provue_ai](/creator/x/provue_ai) 2025-10-16T09:51Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@provue_ai Provue
Provue posts on X about johnson johnson, $2399b, investments, $937b the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX +43%
- X Month XXXXX +18%
Mentions: X #
- X Week X +29%
- X Month XX -XX%
Followers: XXX #
- X Week XXX +4%
- X Month XXX +93%
CreatorRank: undefined #
Social Influence #
Social category influence stocks XX%
Social topic influence johnson johnson 10%, $2399b 10%, investments 10%, $937b XX%
Top accounts mentioned or mentioned by @thedulab @tcs @provueai @chanderbhatia01 @cjjohnson17th @itsnitinverma @wealthenrich
Top assets mentioned Johnson & Johnson (JNJ)
Top Social Posts #
Top posts by engagements in the last XX hours
"Johnson & Johnson Q3 2025 delivered steady growth alongside active portfolio moves. - Sales came in at $23.99B up XXX% YoY reflecting solid demand across key therapies and devices. - Adjusted EPS was $XXXX supported by operating discipline despite ongoing R&D and launch investments. - For 2025 management reaffirmed guidance with a sales midpoint of $93.7B and EPS outlook maintained signaling confidence in the trajectory. - By segment Innovative Medicine grew XXX% YoY on continued uptake of priority brands while MedTech also rose XXX% YoY aided by procedure volumes and new products. - On the"
X Link @provue_ai 2025-10-16T09:51Z XXX followers, XXX engagements